{
    "Question": "Ybrain Inc. CES 2024 product highlight and specification",
    "Summary": "Ybrain Inc.\n\nProduct: MINDD STIM+\n\n- The world's first depression electroceutical STIM+ approved by the Ministry of Food and Drug Safety KOREA\n- Non-invasive transcranial electrical stimulation (tES) and transcutaneous nerve stimulation (tNS) based home treatment management technologies\n- Provides at-home treatment for major depressive disorder and other psychiatric illnesses\n- Utilizes dry electrodes for stable signal quality and convenience\n- Offers mental health management solution through mental health self-scale tests and mental health monitoring based on bio-signals such as EEG and HRV\n- Provides a BCI solution based on wireless, multi-channel, dry EEG measurement and analysis system\n- Electroceutical solution verified by the MFDS in Korea includes non-invasive waveform technology for cranial nerve electrical stimulation and at-home treatment management technology\n- Pola, a stress-reducing solution, is a non-drug alternative for relieving stressors leading to depression, anxiety, and insomnia, approved by the Korean Ministry of Food and Drug Safety\n- Mental health care app, KLAR, allows users to monitor their sleep patterns, mood, stress level, and physical condition and improve their mindfulness through the mediation and ASMR features",
    "Summary_cn": "Ybrain公司。\n\n产品：MINDD STIM+\n\n- 世界第一个通过韩国食品药品安全部批准的抑郁症电穿刺STIM+。\n- 非侵入性经颅电刺激（tES）和经皮神经刺激（tNS）的家庭治疗管理技术。\n- 为重性抑郁症和其他精神疾病提供在家治疗。\n- 使用干电极以保证信号质量稳定和便利性。\n- 通过心理健康自测和基于脑电图（EEG）和心率变异（HRV）等生物信号的心理健康监测，提供心理健康管理解决方案。\n- 提供基于无线、多通道、干电极脑电图测量和分析系统的脑机接口（BCI）解决方案。\n- 由韩国食品药品安全部验证的电穿刺解决方案包括无侵入性波形技术用于颅神经电刺激和在家治疗管理技术。\n- Pola是缓解导致抑郁症、焦虑症和失眠的压力源的无药物替代品，已获得韩国食品药品安全部批准。\n- 心理健康护理应用KLAR允许用户监测他们的睡眠模式、心情、压力水平和身体状况，并通过冥想和ASMR功能提高他们的正念水平。"
}